79 related articles for article (PubMed ID: 6097350)
1. [Demonstration of a specific receptor site for glucagon-37 (oxyntomodulin/bioactive enteroglucagon) in rat oxyntic glands].
Depigny C; Lupo B; Kervran A; Bataille D
C R Acad Sci III; 1984; 299(16):677-80. PubMed ID: 6097350
[TBL] [Abstract][Full Text] [Related]
2. Oxyntomodulin: a cAMP-dependent stimulus of rat parietal cell function via the receptor for glucagon-like peptide-1 (7-36)NH2.
Schepp W; Dehne K; Riedel T; Schmidtler J; Schaffer K; Classen M
Digestion; 1996; 57(6):398-405. PubMed ID: 8913701
[TBL] [Abstract][Full Text] [Related]
3. The interaction of glucagon, gastric inhibitory peptide and somatostatin with cyclic AMP production systems present in rat gastric glands.
Gespach C; Bataille D; Dutrillaux MC; Rosselin G
Biochim Biophys Acta; 1982 Feb; 720(1):7-16. PubMed ID: 6174156
[TBL] [Abstract][Full Text] [Related]
4. "Enterolglucagon': a specific effect on gastric glands isolated from the rat fundus. Evidence for an "oxyntomodulin' action.
Bataille D; Gespach C; Coudray AM; Rosselin G
Biosci Rep; 1981 Feb; 1(2):151-5. PubMed ID: 6271273
[TBL] [Abstract][Full Text] [Related]
5. The gastric acid secretagogue gastrin-releasing peptide and the inhibitor oxyntomodulin do not exert their effect directly on the parietal cell in the rat.
Gehl J; Jeppesen JL; Poulsen SS; Holst JJ
Digestion; 1988; 40(3):144-51. PubMed ID: 3234620
[TBL] [Abstract][Full Text] [Related]
6. The biological significance of "enteroglucagon." Present status.
Bataille D; Jarrousse C; Kervran A; Depigny C; Dubrasquet M
Peptides; 1986; 7 Suppl 1():37-42. PubMed ID: 3529053
[TBL] [Abstract][Full Text] [Related]
7. Activation of the hepatic glycine cleavage enzyme system by glucagon and glucagon-related peptides.
Mabrouk GM; Brosnan JT
Can J Physiol Pharmacol; 1997 Sep; 75(9):1096-100. PubMed ID: 9365819
[TBL] [Abstract][Full Text] [Related]
8. [Bioactive "enteroglucagon" (oxyntomodulin): evidence for a C-terminal extension of the glucagon molecule].
Bataille D; Tatemoto K; Coudray AM; Rosselin G; Mutt V
C R Seances Acad Sci III; 1981 Oct; 293(6):323-8. PubMed ID: 6797684
[TBL] [Abstract][Full Text] [Related]
9. Rat parietal cell receptors for GLP-1-(7-36) amide: northern blot, cross-linking, and radioligand binding.
Schmidtler J; Dehne K; Allescher HD; Schusdziarra V; Classen M; Holst JJ; Polack A; Schepp W
Am J Physiol; 1994 Sep; 267(3 Pt 1):G423-32. PubMed ID: 7943240
[TBL] [Abstract][Full Text] [Related]
10. Oxyntomodulin (glucagon-37 or bioactive enteroglucagon): a potent inhibitor of pentagastrin-stimulated acid secretion in rats.
Dubrasquet M; Bataille D; Gespach C
Biosci Rep; 1982 Jun; 2(6):391-5. PubMed ID: 6125221
[No Abstract] [Full Text] [Related]
11. Isolation of glucagon-37 (bioactive enteroglucagon/oxyntomodulin) from porcine jejuno-ileum. Isolation of the peptide.
Bataille D; Coudray AM; Carlqvist M; Rosselin G; Mutt V
FEBS Lett; 1982 Sep; 146(1):73-8. PubMed ID: 7140976
[TBL] [Abstract][Full Text] [Related]
12. The effect of oxyntomodulin (glucagon-37) and glucagon on exocrine pancreatic secretion in the conscious rat.
Biedzinski TM; Bataille D; Devaux MA; Sarles H
Peptides; 1987; 8(6):967-72. PubMed ID: 3441447
[TBL] [Abstract][Full Text] [Related]
13. Bioactive enteroglucagon (oxyntomodulin): present knowledge on its chemical structure and its biological activities.
Bataille D; Gespach C; Tatemoto K; Marie JC; Coudray AM; Rosselin G; Mutt V
Peptides; 1981; 2 Suppl 2():41-4. PubMed ID: 6283496
[TBL] [Abstract][Full Text] [Related]
14. Evidence for a humoral mechanism after small intestinal resection. Exclusion of gastrin but not enteroglucagon.
Sagor GR; Ghatei MA; Al-Mukhtar MY; Wright NA; Bloom SR
Gastroenterology; 1983 May; 84(5 Pt 1):902-6. PubMed ID: 6403403
[TBL] [Abstract][Full Text] [Related]
15. Isolation of glucagon-37 (bioactive enteroglucagon/oxyntomodulin) from porcine jejuno-ileum. Characterization of the peptide.
Bataille D; Tatemoto K; Gespach C; Jörnvall H; Rosselin G; Mutt V
FEBS Lett; 1982 Sep; 146(1):79-86. PubMed ID: 7140977
[TBL] [Abstract][Full Text] [Related]
16. Characterization of high-affinity receptors for truncated glucagon-like peptide-1 in rat gastric glands.
Uttenthal LO; Blázquez E
FEBS Lett; 1990 Mar; 262(1):139-41. PubMed ID: 2156728
[TBL] [Abstract][Full Text] [Related]
17. In vitro effect of glucagon-like peptide-1 (7-36)amide, oxyntomodulin, vasoactive intestinal peptide and somatostatin on gastric acid and pepsinogen secretion.
Ben-Hamida A; Houssein AA; Man WK; Spencer J
Inflamm Res; 1997 Mar; 46 Suppl 1():S105-6. PubMed ID: 9098788
[No Abstract] [Full Text] [Related]
18. Gastrointestinal satiety signals III. Glucagon-like peptide 1, oxyntomodulin, peptide YY, and pancreatic polypeptide.
Stanley S; Wynne K; Bloom S
Am J Physiol Gastrointest Liver Physiol; 2004 May; 286(5):G693-7. PubMed ID: 15068960
[TBL] [Abstract][Full Text] [Related]
19. Comparative effects of GLP-1-(7-36) amide, oxyntomodulin and glucagon on rabbit gastric parietal cell function.
Gros L; Hollande F; Thorens B; Kervran A; Bataille D
Eur J Pharmacol; 1995 Feb; 288(3):319-27. PubMed ID: 7774676
[TBL] [Abstract][Full Text] [Related]
20. Gut hormones and the control of appetite.
Small CJ; Bloom SR
Trends Endocrinol Metab; 2004 Aug; 15(6):259-63. PubMed ID: 15358278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
